XML 136 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Unaudited) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Investments:    
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $335,626 and $340,870, respectively; includes $4,064 and $3,378, respectively, relating to variable interest entities) $ 356,514 $ 374,266
Equity securities available-for-sale, at estimated fair value (cost: $2,922 and $2,838, respectively) 3,231 2,891
Fair value option and trading securities, at estimated fair value (includes $744 and $659, respectively, of actively traded securities; and $92 and $112, respectively, relating to variable interest entities) 16,110 16,348
Mortgage loans:    
Held-for-investment, principally at amortized cost (net of valuation allowances of $302 and $347, respectively; includes $2,316 and $2,715, respectively, at estimated fair value, relating to variable interest entities) 55,636 56,592
Held-for-sale, principally at estimated fair value (includes $0 and $49, respectively, under the fair value option) 0 414
Mortgage loans, net 55,636 57,006
Policy loans (includes $3 and $0, respectively, relating to variable interest entities) 11,722 11,884
Real estate and real estate joint ventures (includes $9 and $10, respectively, relating to variable interest entities) 9,886 9,918
Other limited partnership interests (includes $159 and $274, respectively, relating to variable interest entities) 7,197 6,688
Short-term investments, principally at estimated fair value (includes $13 and $0, respectively, relating to variable interest entities) 12,990 16,906
Other invested assets, principally at estimated fair value (includes $78 and $81, respectively, relating to variable interest entities) 17,920 21,145
Total investments 491,206 517,052
Cash and cash equivalents, principally at estimated fair value (includes $54 and $99, respectively, relating to variable interest entities) 9,184 15,738
Accrued investment income (includes $26 and $13, respectively, relating to variable interest entities) 4,357 4,374
Premiums, reinsurance and other receivables (includes $16 and $5, respectively, relating to variable interest entities) 23,283 21,634
Deferred policy acquisition costs and value of business acquired (includes $265 and $0, respectively, relating to variable interest entities) 24,782 24,761
Goodwill 9,447 9,953
Other assets (includes $142 and $5, respectively, relating to variable interest entities) 7,830 7,876
Separate account assets (includes $1,096 and $0, respectively, relating to variable interest entities) 245,573 235,393
Total assets 815,662 836,781
Liabilities    
Future policy benefits (includes $458 and $0, respectively, relating to variable interest entities) 184,697 192,351
Policyholder account balances (includes $66 and $0, respectively, relating to variable interest entities) 215,195 225,821
Other policy-related balances (includes $129 and $0, respectively, relating to variable interest entities) 15,279 15,463
Policyholder dividends payable 750 728
Policyholder dividend obligation 2,273 3,828
Payables for collateral under securities loaned and other transactions 33,247 33,687
Bank deposits 0 6,416
Short-term debt 100 100
Long-term debt (includes $2,126 and $2,527, respectively, at estimated fair value, relating to variable interest entities) 18,577 19,062
Collateral financing arrangements 4,196 4,196
Junior subordinated debt securities 3,193 3,192
Current income tax payable 111 401
Deferred income tax liability 6,602 8,693
Other liabilities (includes $90 and $40, respectively, relating to variable interest entities) 25,331 22,492
Separate account liabilities (includes $1,096 and $0, respectively, relating to variable interest entities) 245,573 235,393
Total liabilities 755,124 771,823
Contingencies, Commitments and Guarantees (Note 14)      
Redeemable noncontrolling interests in partially-owned consolidated subsidiaries 130 121
MetLife, Inc.'s stockholders' equity:    
Preferred stock, par value $0.01 per share; 200,000,000 shares authorized: 84,000,000 shares issued and outstanding; $2,100 aggregate liquidation preference 1 1
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,099,795,436 and 1,094,880,623 shares issued at June 30, 2013 and December 31, 2012, respectively; 1,096,601,549 and 1,091,686,736 shares outstanding at June 30, 2013 and December 31, 2012, respectively 11 11
Additional paid-in capital 28,137 28,011
Retained earnings 25,824 25,205
Treasury stock, at cost; 3,193,887 shares at June 30, 2013 and December 31, 2012 (172) (172)
Accumulated other comprehensive income (loss) 6,202 11,397
Total MetLife, Inc.'s stockholders' equity 60,003 64,453
Noncontrolling interests 405 384
Total equity 60,408 64,837
Total liabilities and equity $ 815,662 $ 836,781